Risk of transient vision loss after intravitreal aflibercept using vial-prepared vs. the novel prefilled syringe formulation

Risk of transient vision loss after intravitreal aflibercept using vial-prepared vs. the novel prefilled syringe formulation

PurposeTo compare the risk of transient vision loss (TVL) probably attributable to a severe intraocular pressure spike after intravitreal aflibercept application using the novel prefilled syringe (PFS) vs. the established vial system (VS).MethodsDatasets of the intravitreal injection service of the...

Full description

Bibliographic Details
Main Authors: Julian E. Klaas, Vinh Bui, Niklas Maierhofer, Benedikt Schworm, Mathias Maier, Siegfried G. Priglinger, Jakob Siedlecki
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-10-01
Series:Frontiers in Medicine
Subjects:
Eylea
aflibercept
prefilled syringe
choroidal neovascularization
age related macular degeneration
diabetic macular edema
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2023.1295633/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2023.1295633/full

Similar Items